VitalityHealth has released its 2024 cancer claims analysis, identifying breast, skin, and prostate cancers as the most commonly claimed types.
According to the data, breast cancer accounted for 25.5% of claims, skin cancer for 24.8%, and prostate cancer for 13.6%.
The insurer reported a 9% decrease in breast cancer claims rates and a 7% decrease in prostate cancer claims rates from 2019 to 2024. In contrast, claims rates for skin cancer increased by nearly 25% over the same period.
A breakdown by gender showed that breast cancer was the most common cancer claim among women in 2024, representing 47% of women’s cancer claims, with skin cancer following at 22%. Among men, prostate cancer made up 29% of claims, while skin cancer accounted for 27%. Prostate cancer claims were only submitted by men aged 40 and above.
The rise in skin cancer claims has prompted Vitality to call on the insurance industry to enhance early detection and prevention efforts. Earlier this year, the company urged insurers to improve screening and awareness, aligning its public stance with the trends seen in its own claims data and reflecting a wider industry focus on early intervention for cancer.
VitalityHealth also reported that 77% of its private health insurance customers expressed concerns about waiting times for cancer diagnosis and treatment. This concern was consistent across age groups, with 77% of those aged 18–34 and 78% of those aged 55 and older reporting similar worries.
The company noted that cancer cover remains a significant factor for consumers considering private medical insurance.
Arun Thiyagarajan (pictured above), CEO of VitalityHealth, commented on the findings, saying, “A cancer diagnosis can be absolutely devastating, but having the right kind of clinical treatment and care, alongside wider holistic support... is invaluable and is most likely why it remains a top priority for those seeking to purchase PMI.”
He noted that the reduction in breast and bowel cancer claims rates among Vitality members between 2019 and 2024 was encouraging. Thiyagarajan also addressed the increase in skin cancer claims.
“It’s important to remember skin cancer remains one of the most treatable forms of cancer. By embedding timely screening within a well-guided care journey, we can help ensure it is identified early and managed effectively,” Thiyagarajan said.
What are your thoughts on this story? Please feel free to share your comments below.
